CYFRA 21-1 - ABBOTT Diagnostics
CYFRA 21-1 levels (ng·ml -1 ) in lung cancer according to TNM stage | Download Table
CYFRA 21-1 DISTRIBUTION IN NON-SMALL CELL LUNG CANCER | Download Table
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma
CYFRA 21-1 Serum Analysis in Patients with Esophageal Cancer | Clinical Cancer Research
Table 2 from A COMPARISON OF CYFRA 21-1, NSE, AND CEA FOR THE SERODIAGNOSIS OF LUNG CANCER | Semantic Scholar
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer - Lung Cancer
![PDF] Diagnostic Efficiency of HE 4 and CYFRA 21-1 in Patients with Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cd263048f28601d7e30e6736743509acf69a5df7/4-Table3-1.png "PDF] Diagnostic Efficiency of HE 4 and CYFRA 21-1 in Patients with Lung Cancer | Semantic Scholar")
PDF] Diagnostic Efficiency of HE 4 and CYFRA 21-1 in Patients with Lung Cancer | Semantic Scholar
IVD Antibody Development Services for CYFRA21-1 Marker - Creative Biolabs
CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients
Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis - ScienceDirect
Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - Journal of Thoracic Oncology
Elevation of cytokeratin 19 fragment (CYFRA 21-1) in serum of patients with radiation pneumonitis: possible marker of epithelial cell damage - Respiratory Medicine
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer
Sigma Diagnostics | CYFRA 21-1
Table 1 from Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | Semantic Scholar
Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer - Yoshimura - Translational Lung Cancer Research
Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
Ultrasensitive label-free detection for lung cancer CYFRA 21-1 DNA based on ring-opening polymerization - ScienceDirect
PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
